The invention directs to a drug carrier and a pharmaceutical composition including the same. The drug carrier has a Na-Ni particle and a carbon nanofiber. The carbon nanofiber is formed on the Na-Ni particle and modified with a hydrophilic group on its surface. By cell viability assay, the drug carrier is proven to be tumor-specific, and able to be loaded with an anti-cancer drug and to deliver the drug to a tumor cell without any tumor targeting agent.本發明攸關一種醫藥載體及含其的醫藥組成物。醫藥載體含有Na-Ni粒子及奈米碳纖維管,其中奈米碳纖維管是包覆形成於Na-Ni粒子上,且奈米碳纖維管的表面修飾有親水性基團。經細胞存活分析證實,本發明的醫藥載體本身就具有腫瘤靶向性,因而不須腫瘤靶向分子,即可附載一抗癌藥物並輸送至腫瘤細胞。無
